Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión) Open Journal Systems
Esclerosis múltiple y virus de Epstein-Barr: Una asociación a destacar
Resumen
La etiología en la esclerosis múltiple es un campo elusivo debido a la carencia del modelo etiológico directo para explicar la enfermedad. De hecho, con toda la evidencia que ahora se tiene, la esclerosis múltiple se comienza a ver como una enfermedad multifactorial donde un agente infeccioso en un ambiente permisivo y en un huésped susceptible, puede crear una reacción inflamatoria, desmielinización y daño neurológico irreversible con consecuencias devastadoras para los pacientes. Esta revisión se enfocará en el papel de los virus en la etiología de esclerosis múltiple, especialmente del virus Epstein-Barr.
Palabras clave
Texto completo:
PDFReferencias
Gilden DH. Infectious causes of multiple sclerosis. Lancet Neurol 2005;4:195-202.
Willer CJ, Dyment DA, Risch NJ, Sadovnick AD. Twin concordance and sibling recurrence rates in
multiple sclerosis. Proc Natl Acad Sci USA 2003; 100:12877-12882.
Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation or viral persistence: Infectious and autoimmune disease. Clin Microbiol Rev 2006;19(1):80-94.
Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005; 15:179-211.
Christensen T, Sorensen PD, Hansen HJ, Moller-Larsen A. Antibodies against a human endogenous
retrovirus and the preponderance of Env splice variant in multiple sclerosis patients. Mult Scler 2003; 9:6-15
Reiber H, Ungefehr S, Jacobi C. Intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998;4:111-117
Bray PF, Luka J, Bray PF, Culp KW, Schlight JP. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis cerebrospinal fluid, and two pentapeptide sequence identifies between EBNA and myelin basic protein. Neurology 1992; 42:1798-1804.
Layh-Schmitt G, Bendl C, Hildt U, Dong-Si T, Juttler E, Schnitzler P, et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol 2000;47:652-655.
Krametter D, Niederwieser G, Berghold A, Bimbaum G, Strasser-Fuchs S, Hartung HP, et al. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 2001;7(1):13-18.
Munger KL, Peeling RW, Hernan MA, Chasan-Taber L, Olek MJ, Hankinson SE, et al. Chlamydia pneumonie and risk of multiple sclerosis. Epidemiology 2003;14:141-147.
Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004;3:709-718.
Christensen T. The role of EBV in MS pathogenesis. Int MS J. 2006 May;13(2):52-7
Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993;6(4):382-427.
Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol. 2002;2(2):85-95.
Fujinami RS, Zurbriggen A, Powel HC. Monoclonal antibody defines determinant between Theiler’s virus and lipid-like structures. J Neuroimmunol 1988;20(1):25-32.
Duke RC. Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J Exp Med. 1989;170(1):59-71.
Srinivasappa JJ, Saegusa BS, Prabhakar MK, Gentry MJ, Buchmeier TJ, Witkor H, et al. Molecular mimicry: frequency of reactivation of monoclonal antiviral antibodies with normal tissues. J Virol 1986;57:397-401.
Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis. JAMA. 2001;286:3083-3088.
Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, et al. Temporal relationship between elevation of Epstein-Barr virus antibodies titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293:2496-2500.
Ponsonby AL, van der Mei I, Dwyer T, Blizzard L, Taylor B, Kemp A, et al. Exposure to infant sibling during early life and risk of multiple sclerosis. JAMA 2005; 293:463-469.
Aloitaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291:1875-1879.
Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health 2004; 58: 1032-1035.
Pohl D, Krone B, Rostasy K, Kahler E, Brunner E, Lehnert M, et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006; 67:2063-2065.
Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis. Neurology 2004;62:2277-2282.
Henle W, Henle G, Anderson J, Ernberg I, Klein G, Horwitz CA, et al. Antibody response to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci 1987; 84:570-574.
Wandinger KP, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner HJ, et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000;55:164-165.
Buljevac D, van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, et al. Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:1377-1381.
Perron H, Garson JA, Bedin F, Beseme F, Perenhos-Baccala G, Komurian-Pradel F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple slcerosis. Proc Natl Acad Sci 1997;94:7583-7588.
Opsahl ML, Kennedy PG. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 2005;128:516-527.
Liedtke W, MAlessa R, Faustmann PM, Eis-Hubinger AM. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995;1:253-258.
Mirandola P, Stefan P, Brambilla E, Campadelli-Fiume G, Grimaldi LM. Abscense of human herpes virus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 1999;53:1367-1368.
Rodríguez-Carneros S, Martínez-Vázquez C, Potel-Alvarellos C, Álvarez-Fernández M, Prieto-González JM, Noya-García M, et al. Lack of human herpes virus type 6 DNA in CSF by nested PCR among patients with multiple sclerosis. Rev Clin Esp 2002;202:588-591.
Enlaces refback
- No hay ningún enlace refback.